ArticleVaccine2024

Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.

Peter M Dull et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.